课题基金 / 基金详情

Bright Light Treatment At Home To Manage Chronic Pain In U.S. Veterans

Bright Light Treatment At Home To Manage Chronic Pain In U.S. Veterans
在家进行强光治疗来治疗美国退伍军人的慢性疼痛
批准号:
8893901
负责人:
Helen Julia Burgess
金额:
$22.55万
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-08-01 至 2017-07-31

项目摘要

项目成果

Helen Julia Burgess的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请者提供):近50%的美国退伍军人表示,他们经常感到疼痛。这种慢性疼痛通常与其他疾病并存,包括创伤后应激障碍、抑郁、焦虑和失眠。治疗慢性疼痛的一种常见方法是阿片类止痛药,这种药物并不总是有效的,而且越来越多地与滥用和误用有关。因此,迫切需要开发容易获得、安全和实用的补充非药理学方法来管理美国退伍军人的慢性疼痛。慢性疼痛是一种多维现象,与许多因素相互关联,包括负面情绪和睡眠不佳。中央生物钟位于下丘脑的视交叉上核,被公认为调节情绪和睡眠,即使是昼夜节律/睡眠时间的微小延迟(后移)也与抑郁和睡眠中断有关。这些结果表明,较晚的昼夜节律/睡眠时间可能是疼痛的一个可修改的风险因素。我们的试点数据 提示:(1)较晚的昼夜节律/睡眠时间与更糟糕的愤怒、抑郁、焦虑、疲劳和身体功能有关;(2)自我管理的家庭强光疗法在改变昼夜节律阶段方面有效。因此,在家中自我实施强光治疗可能是治疗慢性疼痛的一种潜在有效的辅助策略。这项R34提案将开发一种晨光疗法,帮助控制慢性疼痛,并改善美国退伍军人的创伤后应激障碍症状、抑郁、焦虑和睡眠。患者将在家中有7天的基线时间,然后是基线疼痛敏感性评估和家庭昼夜节律阶段评估(昏暗的光线褪黑素开始)。在指导性的家访之后,患者将进行为期6天的自我晨光治疗,然后重新评估疼痛敏感性和昼夜节律。在另外7天的晨间强光治疗后,将再次进行评估。在整个基线和治疗过程中,每天都会对疼痛、情绪和睡眠(腕部动作图)进行评估。退伍军人还将在停止光线治疗后的1个月内每天对疼痛、情绪和睡眠进行评级。目的1是确定强光治疗慢性下腰痛的美国退伍军人样本(n=30)的可行性和可接受性。目的2是检测6天和13天的强光治疗对他们慢性疼痛强度和敏感性的影响(PTSD症状、情绪和睡眠的改善是次要结果),以揭示影响足够的疼痛缓解反应所需的治疗持续时间。目的3是确定停止光治疗后治疗反应衰减的时间进程,以获得信息,以发展维持强光治疗(例如,每隔2天或3天进行一次强光治疗)。该项目的长期意义在于,需要开发现成、安全和实用的方法来管理美国退伍军人的慢性疼痛,而不仅仅是基于止痛药。更直接的是,该项目将检查围绕实施有效的强光治疗疗程的重要参数,为未来的临床试验提供重要基础。
英文摘要
DESCRIPTION (provided by applicant): Nearly 50% of U.S. veterans report they experience pain on a regular basis. This chronic pain often co-occurs with other disorders including PTSD, depression, anxiety and insomnia. A common approach to treating chronic pain is opioid analgesics, which are not always effective, and increasingly associated with abuse and misuse. Thus, there is an urgent need to develop readily available, safe, and practical complementary non-pharmacological approaches to manage chronic pain in U.S. veterans. Chronic pain is a multidimensional phenomenon, inter-related with many factors, including negative mood and poor sleep. The central circadian clock, in the suprachiasmatic nucleus in the hypothalamus, is well recognized to regulate both mood and sleep, and even small delays (shifts later) in circadian/sleep timing are associated with depression and disrupted sleep. These results suggests that later circadian/sleep timing may be a modifiable risk factor for pain. Our pilot data suggest that: (1) later circadian/sleep timing is associated with worse anger, depression, anxiety, fatigue and physical function; (2) a self-administered home based bright light treatment is effective at shifting circadian phase. Thus, self-administered bright light treatment at home may be a potentially efficacious adjunctive strategy for managing chronic pain. This R34 proposal will develop a morning bright light treatment to help manage chronic pain and improve PTSD symptoms, depression, anxiety and sleep in U.S. veterans. Patients will have 7 baseline days at home, followed by a baseline pain sensitivity assessment and home circadian phase assessment (dim light melatonin onset). Following an instructional home visit, patients will then self- administer morning bright light treatment for 6 days, followed by reassessments of pain sensitivity and circadian phase. Assessments will be repeated after another 7 days of morning bright light treatment. Pain, mood and sleep (wrist actigraphy) will be assessed daily throughout baseline and treatment. Pain, mood and sleep will also be rated by veterans daily during a 1 month follow up after cessation of light treatment. Aim 1 is to determine the feasibility and acceptability of bright light treatment in a sample of U.S. veterans (n=30) experiencing chronic low back pain. Aim 2 is to examine the effects of 6 days and 13 days of bright light treatment on their chronic pain intensity and sensitivity (improved PTSD symptoms, mood and sleep are secondary outcomes) to reveal the treatment duration needed to affect an adequate pain reduction response. Aim 3 is to determine the time course of decay of treatment response after cessation of light treatment to gain information for the development of a maintenance bright light treatment (e.g. bright light every second or third day). Long-term significance of this project addresses the need to develop readily available, safe, and practical approaches to manage chronic pain in U.S. veterans not exclusively based on analgesic medications. More immediately, the project will examine important parameters surrounding the implementation of an effective course of bright light treatment to provide an important foundation for a future clinical trial.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Morning Light Treatment for Inflammatory Bowel Disease: A Pilot Clinical Trial
Morning Light Treatment for Traumatic Stress: the Role of Amygdala Reactivity
The Contribution of Sleep and Circadian Disruption to Kynurenine Pathway Activation and Cardiometabolic Risk in Women with HIV
Bright Light Treatment At Home To Improve Symptom Management of Fibromyalgia Syndrome
海外基金